Information  X 
Enter a valid email address

Oxford Biomedica PLC Ord 1P (OXB)

Related News

17-Sep-2020 07:35 AM

Revenue, cash up for Oxford Biometrica as work starts on COVID-19 vaccine

Biotech company Oxford Biomedica increased its revenue in the first half of 2020 by 6%, it announced this morning. Bioprocessing and commercial development were particularly strong, posting revenues of £23.4m, up by 24%. The company recorded an op
24-Jun-2020 08:00 AM

Broker Forecast - Liberum Capital issues a broker note on Oxford BioMedica PLC

Liberum Capital today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and cut its price target to 1050p (from 1090p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
22-Jun-2020 08:40 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and cut its price target to 1000p (from 1050p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Jun-2020 08:20 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and cut its price target to 1050p (from 1060p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-May-2020 01:30 PM

Broker Forecast - Jefferies International issues a broker note on Oxford BioMedica PLC

Jefferies International today reaffirms its hold investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 730p (from 700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-May-2020 09:20 AM

Oxford Biomedica swings to loss as milestone revenue falls

Gene and cell therapy group Oxford Biomedica swung to a full-year loss, owing to a rise in expenses and fall in revenue. Pre-tax losses for the year through December amounted to £20.9m, compared to a profit of £5.0m on-year. Revenue fell 4%
28-Apr-2020 11:20 AM

Broker Forecast - Liberum Capital issues a broker note on Oxford BioMedica PLC

Liberum Capital today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 1090p (from 860p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Jan-2020 10:50 AM

Broker Forecast - Liberum Capital issues a broker note on Oxford BioMedica PLC

Liberum Capital today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 860p (from 810p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
04-Sep-2019 07:39 AM

Oxford Biomedica losses deepen as sales fall, R&D costs rise

Gene and cell therapy company Oxford Biomedica booked a deeper first-half loss, after sales fell and it upped spending on R&D. Pre-tax losses for the six months through June amounted to £12.1m, compared to a profit of £5.2m on-year. Revenues
28-May-2019 08:00 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 1060p (from 1010p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Mar-2019 08:10 AM

Broker Forecast - Jefferies International issues a broker note on Oxford BioMedica PLC

Jefferies International today reaffirms its hold investment rating on Oxford BioMedica PLC (LON:OXB) and cut its price target to 725p (from 800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
04-Jan-2019 08:10 AM

Broker Forecast - Jefferies International issues a broker note on Oxford BioMedica PLC

Jefferies International today reaffirms its hold investment rating on Oxford BioMedica PLC (LON:OXB) and cut its price target to 800p (from 1100p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Sep-2018 08:27 AM

Oxford BioMedica sees 118% jump in gross income, expands bioprocessing capacity

Gene and cell therapy group Oxford BioMedica reported an operating profit of £9.4m for the first half of 2018, compared with a £2.2m loss a year earlier, while gross income jumped 118% to £36m, driven by £20.6 million worth of lice
13-Jun-2018 08:40 AM

Broker Forecast - Jefferies International issues a broker note on Oxford BioMedica PLC

Jefferies International today downgrades its investment rating on Oxford BioMedica PLC (LON:OXB) to hold (from buy) and raised its price target to 1100p (from 825p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmaga
06-Jun-2018 08:40 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 1010p (from 780p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-May-2018 12:40 PM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and set its price target at 16p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
09-Apr-2018 09:50 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and set its price target at 16p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Mar-2018 09:20 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 16p (from 13p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Mar-2018 08:38 AM

Oxford BioMedica cuts EBITDA loss

Oxford BioMedica, a gene and cell therapy group, increased its gross income by 28% to £39.4 million in the year to 31 December 2017. Operating expenses excluding depreciation and amortisation and share based payments decreased by 12% to £22.9
15-Feb-2018 08:41 AM

Oxford BioMedica signs agreement with Bioverativ

Oxford BioMedica, a gene and cell therapy group, has signed a major collaboration and licence agreement with Bioverativ for the development and manufacturing of lentiviral vectors to treat haemophilia. The agreement includes a licence to use OXB's
19-Sep-2017 08:40 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today initiates coverage of Oxford BioMedica PLC (LON:OXB) with a buy investment rating and price target of 13p. Story provided by StockMarketWire.com...
31-Aug-2017 01:00 PM

Broker Forecast - N+1 Singer issues a broker note on Oxford BioMedica PLC

N+1 Singer today reaffirms its hold investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 10.20p (from 8.70p). Story provided by StockMarketWire.com...
17-Aug-2017 07:43 AM

Oxford BioMedica cuts operating loss

Oxford BioMedica made an operating loss of £2.2 million in the first half of 2017, compared with a loss of £6.9 million the year before. Revenue increased by 26% to £15.7 million. Cash outflow before financing activities reduced to &po
11-Aug-2017 09:08 AM

Oxford BioMedica to lead £2m gene therapy collaboration project

Oxford BioMedica has agreed, as lead partner, to enter into a collaboration agreement with a consortium of partners for a two-year £2 million project focused on gene and cell therapy manufacturing, co-funded by Innovate UK. The aim of the collabora
07-Aug-2017 08:20 AM

Oxford BioMedica wins MHRA commercial supply licence

Oxford BioMedica (OXB) has been granted a licence by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture and distribute lentiviral vector material for commercial supply. This is in addition to the existing licence for Invest
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t